Geode Capital Management
RUBY

Geode Capital Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

Geode Capital Management’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-412,218
Closed -$70K – 4884
2022
Q4 		$70K Sell
412,218
-23,428
-5% -$6.4K ﹤0.01% 4508
2022
Q3 		$188K Hold
435,646
– – ﹤0.01% 4250
2022
Q2 		$370K Sell
435,646
-334,990
-43% -$562K ﹤0.01% 3925
2022
Q1 		$4.25M Buy
770,636
+266
+0% +$1.69K ﹤0.01% 2891
2021
Q4 		$7.46M Sell
770,370
-29,138
-4% -$404K ﹤0.01% 2645
2021
Q3 		$14.3M Sell
799,508
-13,789
-2% -$300K ﹤0.01% 2196
2021
Q2 		$19.9M Buy
813,297
+94,744
+13% +$2.37M ﹤0.01% 1970
2021
Q1 		$19M Buy
718,553
+134,421
+23% +$1.96M ﹤0.01% 1913
2020
Q4 		$4.43M Sell
584,132
-22,483
-4% -$134K ﹤0.01% 2668
2020
Q3 		$3.04M Buy
606,615
+13,332
+2% +$70.6K ﹤0.01% 2662
2020
Q2 		$3.55M Buy
593,283
+42,122
+8% +$249K ﹤0.01% 2519
2020
Q1 		$2.45M Buy
551,161
+38,291
+7% +$284K ﹤0.01% 2568
2019
Q4 		$4.87M Buy
512,870
+21,000
+4% +$203K ﹤0.01% 2473
2019
Q3 		$3.86M Buy
491,870
+156,230
+47% +$1.82M ﹤0.01% 2538
2019
Q2 		$5.28M Buy
335,640
+31,016
+10% +$500K ﹤0.01% 2350
2019
Q1 		$5.51M Buy
304,624
+106,087
+53% +$1.63M ﹤0.01% 2272
2018
Q4 		$3.19M Buy
198,537
+36,692
+23% +$669K ﹤0.01% 2496
2018
Q3 		$3.88M Buy
+161,845
New +$3.7M ﹤0.01% 2519

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Geode Capital Management's RUBY Position: Q1 2023 in Review

Geode Capital Management sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 412,218 shares — an estimated $70K sold.

Geode Capital Management first reported a position in RUBY in Q3 2018 and held it in 18 quarters. The position peaked at $19.9M in Q2 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Geode Capital Management reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Geode Capital Management sold 412,218 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $70K.
  • Geode Capital Management first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 18 quarters.
  • Geode Capital Management's Rubius Therapeutics, Inc position peaked at $19.9M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.